Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Aug-22 7:02 PM View:  | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition | 22,054 | -- | -- | (< 1%) 3.4M to 3.38M | |
| 16-Aug-22 7:02 PM View: | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition | 3,380,950 | -- | -- | (100%) 3.38M to 0 | |
| 19-May-22 4:23 PM View: | Epizyme, Inc. (EPZM) | 17-May-22 | Grant | 8,994 | -- | -- | < 1% 3.39M to 3.4M | |
| 15-Jun-21 4:35 PM View: | Epizyme, Inc. (EPZM) | 11-Jun-21 | Grant | 8,060 | -- | -- | < 1% 3.39M to 3.39M | |
| 13-Nov-20 7:05 AM View: | Epizyme, Inc. (EPZM) | 11-Nov-20 | Market Purchase | 5,000 | $12.07 | $60,350.00 | < 1% 3.38M to 3.39M | (2%) |
| 04-Nov-20 8:00 PM View: | Galecto, Inc. (GLTO) | 02-Nov-20 | Conversion | 9,587 | -- | -- | 100% 0 to 9.59K | |
| 04-Nov-20 8:00 PM View: | Galecto, Inc. (GLTO) | 02-Nov-20 | Conversion | 1,039,470 | -- | -- | 10843% 9.59K to 1.05M | |
| 16-Mar-20 5:12 PM View: | Enliven Therapeutics, Inc. (ELVN) | 16-Mar-20 | Conversion Duplicate | 703,380 | -- | -- | 102% 690.23K to 1.39M | |
| 08-Feb-19 8:21 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 07-Feb-19 | Option Exercise | 11,675 | $5.40 | $63,045.00 | 100% 0 to 11.68K | |
| 08-Feb-19 8:21 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 07-Feb-19 | Market Option Sale | 11,675 | $9.02 | $105,328.00 | (100%) 11.68K to 0 | 27% |
| 23-Mar-18 4:56 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 22-Mar-18 | Option Exercise | 15,000 | $5.19 | $77,830.00 | 100% 0 to 15.0K | |
| 23-Mar-18 4:56 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 22-Mar-18 | Option Sale | 15,000 | $13.02 | $195,375.00 | (100%) 15.0K to 0 | |
| 06-Nov-17 8:45 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 02-Nov-17 | Option Exercise | 18,000 | $2.35 | $42,210.00 | 100% 0 to 18.0K | |
| 06-Nov-17 8:45 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 02-Nov-17 | Option Sale | 18,000 | $8.66 | $155,880.00 | (100%) 18.0K to 0 | |
| 26-May-17 3:10 PM View: | EnteroMedics, Inc. (RSLS) | 25-May-17 | Market Sale | 4,668 | $4.85 | $22,639.80 | (100%) (-4.67K) to 0 | (100%) |
| 12-Jan-16 4:32 PM View: | Epizyme, Inc. (EPZM) | 12-Jan-16 | Private Purchase | 555,555 | $9.00 | $5,000,000.00 | 9% 6.2M to 6.75M | |
| 11-Sep-15 5:28 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 11-Sep-15 | Sale | 15,467 | $2.76 | $42,689.10 | (89%) 17.43K to 1.96K | |
| 11-Sep-15 5:28 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 10-Sep-15 | Sale | 16,500 | $2.71 | $44,715.00 | (49%) 33.93K to 17.43K | |
| 11-Sep-15 5:28 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 09-Sep-15 | Sale | 14,762 | $2.76 | $40,743.10 | (30%) 48.69K to 33.93K | |
| 05-Sep-14 7:30 PM View: | Epizyme, Inc. (EPZM) | 04-Sep-14 | Private Sale | 4,000 | $35.14 | $140,560.00 | (< 1%) 2.83M to 2.83M | |
| 28-Aug-14 6:11 PM View: | Epizyme, Inc. (EPZM) | 26-Aug-14 | Market Sale Duplicate | 200,000 | $35.14 | $7,027,800.00 | (3%) 5.85M to 5.65M | 69% |
| 25-Aug-14 6:29 PM View: | Epizyme, Inc. (EPZM) | 25-Aug-14 | Market Sale Duplicate | 200,000 | $35.14 | $7,027,800.00 | (3%) 5.85M to 5.65M | 69% |
| 25-Aug-14 6:29 PM View: | Epizyme, Inc. (EPZM) | 22-Aug-14 | Market Sale Duplicate | 128,000 | $32.46 | $4,154,760.00 | (2%) 6.18M to 6.05M | 66% |
| 25-Aug-14 6:29 PM View: | Epizyme, Inc. (EPZM) | 21-Aug-14 | Market Sale Duplicate | 38,666 | $33.04 | $1,277,340.00 | (< 1%) 6.35M to 6.31M | 67% |
| 12-Feb-14 3:01 PM View: | Epizyme, Inc. (EPZM) | 10-Feb-14 | Market Sale Duplicate | 466,667 | $29.25 | $13,650,000.00 | (7%) 6.86M to 6.39M | 64% |
| 07-Jun-13 12:51 PM View: | Epizyme, Inc. (EPZM) | 05-Jun-13 | Conversion Duplicate | 3,492,060 | -- | -- | 96% 3.66M to 7.15M | |
| 07-Jun-13 12:51 PM View: | Epizyme, Inc. (EPZM) | 05-Jun-13 | Purchase Duplicate | 166,666 | $15.00 | $2,499,990.00 | 2% 7.15M to 7.31M | |
| 26-Sep-11 6:11 PM View: | EnteroMedics, Inc. (RSLS) | 23-Sep-11 | Market Purchase Duplicate | 840,000 | $1.65 | $1,386,000.00 | 21% 4.06M to 4.9M | (100%) |
| 10-Jun-11 4:49 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 09-Jun-11 | Option Exercise | 36,145 | -- | -- | 13% 282.82K to 318.96K | |
| 16-Dec-10 5:55 PM View: | EnteroMedics, Inc. (RSLS) | 14-Dec-10 | Conversion Duplicate | 1,626,020 | -- | -- | 220% 738.43K to 2.36M | |
| 16-Dec-10 5:55 PM View: | EnteroMedics, Inc. (RSLS) | 14-Dec-10 | Private Purchase Duplicate | 1,700,000 | $1.74 | $2,958,000.00 | 72% 2.36M to 4.06M | |
| 16-Mar-10 6:32 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 16-Mar-10 | Private Sale | 115,610 | $16.20 | $1,872,880.00 | (2%) 5.62M to 5.51M | |
| 16-Mar-10 6:32 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 15-Mar-10 | Private Sale | 42,176 | $16.01 | $675,238.00 | (< 1%) 5.66M to 5.62M | |
| 16-Mar-10 6:32 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 12-Mar-10 | Private Sale | 105,000 | $16.30 | $1,711,500.00 | (2%) 5.77M to 5.66M | |
| 11-Mar-10 6:41 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 11-Mar-10 | Private Sale | 54,300 | $16.06 | $872,058.00 | (< 1%) 6.32M to 6.26M | |
| 11-Mar-10 6:41 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 10-Mar-10 | Private Sale | 134,190 | $16.03 | $2,151,070.00 | (2%) 6.45M to 6.32M | |
| 11-Mar-10 6:41 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 09-Mar-10 | Private Sale | 151,424 | $15.50 | $2,347,070.00 | (2%) 6.6M to 6.45M | |
| 20-Feb-09 7:40 PM View: | EnteroMedics, Inc. (RSLS) | 19-Feb-09 | Market Purchase Duplicate | 1,649,480 | $1.15 | $1,896,910.00 | 59% 2.78M to 4.43M | (100%) |
| 28-Oct-08 6:07 PM View: | EnteroMedics, Inc. (RSLS) | 24-Oct-08 | Market Purchase | 49,600 | $1.10 | $54,560.00 | 2% 2.73M to 2.78M | (100%) |
| 30-Apr-08 5:45 PM View: | EnteroMedics, Inc. (RSLS) | 29-Apr-08 | Market Purchase Duplicate | 25,000 | $4.50 | $112,500.00 | < 1% 2.71M to 2.73M | (100%) |
| 28-Apr-08 4:39 PM View: | EnteroMedics, Inc. (RSLS) | 24-Apr-08 | Market Purchase Duplicate | 50,000 | $4.50 | $225,000.00 | 2% 2.66M to 2.71M | (100%) |
| 04-Mar-08 5:49 PM View: | EnteroMedics, Inc. (RSLS) | 29-Feb-08 | Market Purchase | 20,990 | $8.66 | $181,773.00 | < 1% 2.64M to 2.66M | (100%) |
| 20-Nov-07 11:40 AM View: | EnteroMedics, Inc. (RSLS) | 20-Nov-07 | Conversion Duplicate | 2,260,500 | -- | -- | 603% 375.0K to 2.64M | |
| 19-Nov-07 4:42 PM View: | EnteroMedics, Inc. (RSLS) | 15-Nov-07 | Market Purchase Duplicate | 375,000 | $8.00 | $3,000,000.00 | 100% 0 to 375.0K | (100%) |
| 12-Oct-07 3:02 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 11-Oct-07 | Conversion Duplicate | 2,170,610 | $14.50 | $31,478,100.00 | 1230% 176.47K to 2.35M | (73%) |
| 12-Oct-07 3:02 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 11-Oct-07 | Acquisition (other) Duplicate | 176,470 | $14.50 | $2,559,170.00 | 8% 2.35M to 2.52M | (73%) |
| 31-Aug-07 5:39 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 30-Aug-07 | Market Purchase | 3,712 | $5.90 | $21,896.20 | 1% 275.77K to 279.48K | (100%) |
| 31-Aug-07 5:24 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 29-Aug-07 | Market Purchase | 244 | $5.75 | $1,402.39 | < 1% 275.53K to 275.77K | (99%) |
| 16-Aug-07 7:36 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 16-Aug-07 | Market Purchase | 227 | $5.48 | $1,244.82 | < 1% 275.3K to 275.53K | (99%) |
| 16-Aug-07 7:36 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 14-Aug-07 | Market Purchase | 29 | $5.50 | $159.50 | < 1% 275.27K to 275.3K | (99%) |